InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Gaston-Dreyfus Remi, Director. Officer active across 1 company, notably Bionik Laboratories Corp.. Cumulatively, 7 reports have been logged. Breakdown: 2 buys · 0 sell. History available since 31 March 2022. The latest transaction was filed on 31 March 2022 (C). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
77,887 shares@ US$9.5024.29% mcap100.0% of flowCommon Stock, par value $0.001 per shareSEC:0001104659-22-073083:0
61,256 sharesCommon Stock, par value $0.001 per shareSEC:0001104659-21-149126:0
135,560 sharesCommon Stock, par value $0.001 per shareSEC:0001104659-21-149123:0
Ideal exit: 21 Dec 2021 (T+270)
115,759 sharesCommon Stock, par value $0.001 per shareSEC:0001104659-21-149127
115,759 sharesCommon Stock, par value $0.001 per shareSEC:0001104659-21-149127:0
135,560 sharesCommon Stock, par value $0.001 per shareSEC:0001104659-21-149123
Ideal exit: 21 Dec 2021 (T+270)
61,256 sharesCommon Stock, par value $0.001 per shareSEC:0001104659-21-149126
7 of 7 declarations
About Gaston-Dreyfus Remi
Remi Gaston-Dreyfus is a Board Member at Bionik Laboratories Corp. He actively participates in the governance of the company, bringing his expertise in the medical technology sector. His role includes overseeing operations and contributing to the company's strategy. Through his experience, he helps guide Bionik towards sustainable growth and innovation.
